Trial intelligence / Profile preview

Autologous FMT for Microbiome Restoration After Antimicrobials

NCT02046525Phase 2Completed

Sponsor
Washington University School of Medicine
Start
Mar 2014
Primary completion
Dec 2018
Modality
Live Biotherapeutic Products
Countries
1
01

Overview

Phase 2, randomised trial in Dysbiosis (2 arms), sponsored by Washington University School of Medicine. Primary endpoint: Number of Participants With Restoration of Microbial Community Composition to the Pre-antibiotic State at 90 days. Started Mar 2014; status: completed.

02

Conditions

Dysbiosis

Beyond the preview

Go deeper on NCT02046525.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02046525.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call